Scientists have uncovered a surprising new way the immune system fights cancer, overturning a core belief that has guided immunology for decades. The research found that when cancer cells shut down a key immune-recognition molecule called MHC I—a common trick used to hide from “killer” T cells—they can actually become more vulnerable to attack by a different group of immune cells known as CD4+ “helper” T cells.
Trending
- Age- and sex-dependent associations of metabolic syndrome with colorectal cancer in the UK Biobank
- Patient cell drug profiling identifies p53-linked vulnerabilities in refractory lymphoid malignancies
- OTUD6A promotes de novo pyrimidine synthesis by deubiquitinating and stabilizing CAD in cervical cancer
- Atezolizumab Plus Chemotherapy Improves PFS in dMMR/MSI-H Metastatic CRC
- FDA Advisory Committee Backs RP1/Nivolumab for Advanced Melanoma
- CAR T-Cell Therapy Could Soon Expand Into Non-Oncology Indications
- TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions
- Capricor’s data clash with the FDA| STAT
Friday, July 31
